Stephen M. Notestine active positions
| Companies | Position | Start | End |
|---|---|---|---|
Sequoia Sciences, Inc.
 Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Director/Board Member | 31/12/1998 | - |
| Quadrant Properties LLC | Founder | 28/09/2009 | - |
| Corporate Officer/Principal | 28/09/2009 | - | |
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Director/Board Member | 31/12/2020 | - |
| Independent Dir/Board Member | 31/12/2020 | - | |
| Roman Catholic Foundation of Eastern Missouri | Director/Board Member | - | - |
Career history of Stephen M. Notestine
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 3 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Health Technology |
| Quadrant Properties LLC | |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
| Roman Catholic Foundation of Eastern Missouri |
- Stock Market
- Insiders
- Stephen M. Notestine
- Experience
